Stock Events

Stock Events

XOMA Royalty 

$25.52
66
-$0.01-0.04% Today

Statistics

Day High
25.53
Day Low
25.45
52W High
26.25
52W Low
25
Volume
2,704
Avg. Volume
-
Mkt Cap
316.01M
P/E Ratio
25.34
Dividend Yield
8.2%
Dividend
2.09

Upcoming

3
JUL
Dividend Ex
Estimated
 
15
JUL
Dividend Payment
Estimated
 
5
OCT
Dividend Ex
Estimated
 
15
OCT
Dividend Payment
Estimated
 
4
JAN 27
Dividend Ex
Estimated
 

Dividends

8.2%Dividend Yield
Apr 26
$0.52
Jan 26
$0.52
Oct 25
$0.52
Jul 25
$0.52
Apr 25
$0.52
10Y Growth
N/A
5Y Growth
14.12%
3Y Growth
N/A
1Y Growth
N/A

Earnings

30AprExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
-1.59
-0.78
0.03
0.84
Expected EPS
0.1575
Actual EPS
N/A

Financials

-48.52%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
56.97MRevenue
-27.64MNet Income

Analyst Ratings

74.33Average Price Target
The highest estimate is 97.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XOMAO. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.35B
Regeneron Pharmaceuticals competes in the biotechnology industry focusing on developing and commercializing medicines for serious medical conditions, similar to XOMA's focus on antibody-based therapeutics.
AMGEN
AMGN
Mkt Cap191.53B
Amgen is a biopharmaceutical company that discovers, develops, manufactures, and delivers innovative human therapeutics, competing directly with XOMA in the biotech sector.
Biogen
BIIB
Mkt Cap26.03B
Biogen competes with XOMA in the biotechnology field, focusing on developing therapies for neurological and neurodegenerative diseases.
Gilead Sciences
GILD
Mkt Cap170.84B
Gilead Sciences is a biopharmaceutical company that researches, develops, and commercializes drugs in areas similar to XOMA, making them direct competitors.
Vertex Pharmaceuticals
VRTX
Mkt Cap112.22B
Vertex Pharmaceuticals is involved in creating new possibilities in medicine to cure diseases and improve people's lives, competing with XOMA in the biotech innovation space.
Alnylam Pharmaceuticals
ALNY
Mkt Cap41.32B
Alnylam Pharmaceuticals is a leader in RNAi therapeutics, competing with XOMA in the development of novel therapeutics.
Incyte
INCY
Mkt Cap19.47B
Incyte Corporation focuses on the discovery, development, and commercialization of proprietary therapeutics, making it a competitor in the biopharmaceutical space alongside XOMA.
Nektar Therapeutics
NKTR
Mkt Cap2.43B
Nektar Therapeutics is involved in developing new treatment options in various therapeutic areas, competing with XOMA in the innovation of biologic drugs.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.51B
BioMarin Pharmaceutical focuses on developing and commercializing innovative biopharmaceuticals for rare diseases, competing with XOMA in targeting niche markets with specialized treatments.

About

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Show more...
CEO
Mr. Owen P. Hughes Jr.
Employees
13
Country
Bermuda
ISIN
US98419J4040

Listings

F
DE
X0M1.F
MU
DE
X0M1.MU
F
DE
X0M.F
BOATS
BOATS
XOMAO.BOATS

0 Comments

Share your thoughts

FAQ

What is XOMA Royalty stock price today?▼
The current price of XOMAO is $25.52 USD — it has decreased by -0.04% in the past 24 hours. Watch XOMA Royalty stock price performance more closely on the chart.
What is XOMA Royalty stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange XOMA Royalty stocks are traded under the ticker XOMAO.
Is XOMA Royalty stock price growing?▼
XOMAO stock has fallen by -0.16% compared to the previous week, the month change is a +0.75% rise, over the last year XOMA Royalty has showed a +1.1% increase.
What is XOMA Royalty market cap?▼
Today XOMA Royalty has the market capitalization of 316.01M
When is the next XOMA Royalty earnings date?▼
XOMA Royalty is going to release the next earnings report on April 30, 2026.
What were XOMA Royalty earnings last quarter?▼
XOMAO earnings for the last quarter are 0.7 USD per share, whereas the estimation was -0.04 USD resulting in a +1,850% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is XOMA Royalty revenue for the last year?▼
XOMA Royalty revenue for the last year amounts to 56.97M USD.
What is XOMA Royalty net income for the last year?▼
XOMAO net income for the last year is -27.64M USD.
Does XOMA Royalty pay dividends?▼
Yes, XOMAO dividends are paid quarterly. The last dividend per share was 0.52 USD. As of today, Dividend Yield (FWD)% is 8.2%.
How many employees does XOMA Royalty have?▼
As of April 22, 2026, the company has 13 employees.
In which sector is XOMA Royalty located?▼
XOMA Royalty operates in the Health & Wellness sector.
When did XOMA Royalty complete a stock split?▼
XOMA Royalty has not had any recent stock splits.
Where is XOMA Royalty headquartered?▼
XOMA Royalty is headquartered in EmeryVille, Bermuda.